Redwood Investments, LLC Vericel Corp Transaction History

Redwood Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$7.25 - $19.22 $6.38 Million - $16.9 Million	-880,147 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$13.77 - $19.2 $9,446 - $13,171	-686 Reduced 0.08%	880,147 $15.3 Million
Q3 2019 Nov 12, 2019	BUY	$14.93 - $19.83 $683,017 - $907,182	45,748 Added 5.48%	880,833 $13.3 Million
Q2 2019 Jul 26, 2019	BUY	$15.01 - $18.89 $12.5 Million - $15.8 Million	835,085 New	835,085 $15.8 Million

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.